Dr. Bill Groutas, Wichita State University medical chemist, is part of a team of scientists from highly respected research institutions that has published a study showing a possible therapeutic treatment for COVID-19. Groutas is part of the team that published “3C-like protease inhibitors block SARS-CoV-2 replication in vitro and increase survival in MERS-CoV-infected mice”— which appeared in the Aug. 3 issue of the prestigious medical journal Science Translational Medicine. It reveals how small molecule protease inhibitors show potency against human coronaviruses. These coronavirus 3C-like proteases, known as 3CLpro, are strong therapeutic targets because they play vital roles in coronavirus replication.